Trustmark (TRMK) Q4 2025 Earnings Transcript

Trustmark reported record 2025 net income of $224.1 million and record full-year revenue of $800 million, with diluted EPS of $3.70 and tangible book value per share up 13.5% to $30.28. Management guided 2026 loans, deposits, net interest income, noninterest income, and noninterest expense to mid-single-digit growth, while NIM is expected to hold in a tight 3.8%-3.85% range and credit costs to normalize at 13-15 bps of average loans. The board raised the quarterly dividend 4.2% to $0.25 and authorized up to $100 million of buybacks, though management suggested 2026 repurchases are more likely in the $60 million-$70 million range.

Analysis

TRMK is shaping up as a quality compounder inside a sleepy regional-bank wrapper: the key signal is not the headline earnings beat, but that management is proving it can still grow tangible book while returning a majority of earnings and keeping capital comfortably above target. That combination usually re-rates banks only after the market believes the cycle is durable; here, the evidence points to operating leverage from mix shift rather than pure rate beta, which is more defensible over the next 6-12 months.

The more interesting second-order effect is that the bank’s expense step-up is intentionally back-half loaded, while funding costs are already easing into 1Q. That creates a setup where first-half earnings can look cleaner than the annual guidance implies, and the market may underwrite the wrong run-rate if it focuses on the full-year mid-single-digit expense call. If loan growth holds and deposit beta keeps improving, the guide leaves room for estimate creep even without any macro help.

The biggest hidden optionality is not M&A itself, but disruption-driven share gain in the bank’s footprint. Management is explicitly positioned to recruit from transaction noise around them, which can accelerate C&I and equipment finance growth without paying for an acquisition; that is a lower-risk path to earnings accretion than a deal and could surprise consensus if competitor integration issues linger. The contrarian risk is that this is still a regional lender with a capital-light buyback story: if credit normalizes faster than expected or deposit competition re-accelerates, the market will compress the multiple before it gives credit for TBV growth.

Key Decisions for Investors

• Go long TRMK on pullbacks for a 3-6 month horizon; thesis is TBV accretion plus buybacks/dividend growth with limited balance-sheet risk. Target a rerate if the market starts capitalizing 2026 EPS at a higher multiple; cut the trade if deposit costs re-expand above guidance or CET1 drifts materially below 11.5%.
• Pair trade: long TRMK / short a higher-beta regional bank ETF or a slower-growing peer with weaker deposit mix, for 1-2 quarters. The edge is TRMK’s better capital return visibility and lower funding pressure; risk is a broad regional-bank multiple expansion that lifts the short leg disproportionately.
• Use TRMK Jan/Apr call spreads rather than outright stock if you expect consensus revisions after 1Q guidance confirmation. The asymmetry is favorable because the market may be underestimating first-half margin support from declining deposit costs before expense seasonality hits.
• If you want a lower-risk expression, sell out-of-the-money puts 1-2 quarters out at strikes near recent support, funded by owning common. This monetizes the market’s usual skepticism toward regional banks while keeping upside from TBV compounding.
• Avoid chasing on M&A headlines alone; any deal would be optionality, not the core driver. The cleaner catalyst is continued organic share gain from competitor disruption, which should be watched through loan growth, deposit mix, and fee-income momentum over the next two quarters.